Startup profile · funding coverage
Sabi funding, valuation and investors
A non-invasive brain-computer-interface startup developing EEG sensors embedded in an everyday baseball cap.
Keep track of Sabi
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$50M · October 9, 2026
Latest known valuation
Reported $600M post-money
Seed · October 9, 2026
Total disclosed equity funding
$50M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · San Francisco, California
Investors in latest funding
Lead: Khosla Ventures
Other: Accel , Initialized Capital , DST Global , Collaborative Fund , Ascend
Overview
Sabi is building a brain-AI interface that aims to convert imagined words and trained mental commands into text and prompts without surgery, gel or direct scalp contact.
Why Sabi is interesting
A $50 million seed round gives Sabi unusually substantial capital to pursue consumer neurotechnology, but its cap still has to prove accuracy, usability and privacy before planned 2027 availability.
Product & use cases
Sabi’s first device resembles a baseball cap and embeds EEG sensors plus a custom chip. The company plans an early prototype demonstration at CES 2027.
- Thought-to-text input
- Hands-free AI prompts
- Consumer neurotechnology
Key facts
- Raised a $50 million seed led by Khosla Ventures in October 2026.
- Plans to show an early prototype at CES 2027.
- Company claims more than 100,000 hours of labelled neural recordings.
Funding history (newest first)
Seed
2026-10-09 $50M Valuation: Reported $600M post-money- Khosla Ventures (lead)
- Accel (participant)
- Initialized Capital (participant)
- DST Global (participant)
- Collaborative Fund (participant)
- Ascend (participant)
Source: https://finance.yahoo.com/technology/ai/articles/sabi-raises-50-million-seed-173000665.html
Investors in our directory
Funds linked from Sabi's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Sabi claims more than 100,000 hours of labelled neural recordings and a sensor design that reads through hair. Those claims are not yet backed by peer-reviewed product-performance data.
Sabi competes with non-invasive BCI developers such as Merge Labs and Bridge Neurotech, while invasive companies such as Neuralink target higher-bandwidth medical use cases.
-
Merge Labs direct
Non-invasive brain-computer-interface developer backed by prominent AI investors.
-
Bridge Neurotech direct
Developing ultrasound-based non-invasive neural interfaces.
-
Neuralink adjacent
Invasive BCI incumbent focused initially on medical applications.
Industries
Market / IPO context
Note: Forbes reported a $600M post-money valuation for the October 2026 seed round; Sabi did not disclose or confirm the valuation in its financing announcement.
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Sabi's financing or category context.
FAQs about Sabi
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.